eddie_williams_novo

Novo Nordisk makes Eddie Williams senior VP

pharmafile | February 3, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, eddie williams 

Novo Nordisk has promoted Eddie Williams to the position of senior vice president of its biopharmaceuticals unit.

Williams brings three decades of experience in the pharma industry to the firm. He joined Novo Nordisk in 2006 and previously served as the corporate vice president of biopharmaceuticals.

In this capacity, he leads the sales and marketing, business development and new product commercialisation functions for the company’s US biopharma business.

Jesper Hoiland, president of the Denmark-based firm said: “Our biopharmaceutical business will be increasingly important to our growth in the US as we apply the protein expertise developed through our diabetes franchise to helping people with haemophilia and growth disorders manage their conditions more effectively.”

“That business has flourished under Eddie’s experienced leadership. His promotion to senior vice president demonstrates the company’s focus on, and commitment to, our pipeline of life-changing biological therapies.”

Related Content

CHMP recommends Novo Nordisk’s Awiqli for diabetes treatment

Novo Nordisk has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for …

Almirall licenses Novo Nordisk’s anti-IL-21 monoclonal antibody for dermatology treatment

Almirall has announced that it has entered into an exclusive license agreement with Novo Nordisk …

Novo Nordisk shares positive results from COMBINE 3 phase 3a trial

Novo Nordisk has shared topline results from the COMBINE 3 phase 3a trial of once-weeklly …

Latest content